10-Q Filing

RICH PHARMACEUTICALS, INC. CIK: 1504389 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001255294-13-000668`
Period End Date	20130630
Filing Date	20130819
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	nepa-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 40 Income Statement 25 Cash Flow Statement 44

Balance Sheet 40 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$60.00K	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.59K	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$1.59K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$60.00K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.70K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.64K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Due to shareholder	`DueToStockholdersCurrent`	$16.82K	USD	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Due to shareholder	`DueToStockholdersCurrent`	$16.82K	USD	Point-in-time
Loan payable	`LoansPayableCurrent`	-	USD	Point-in-time
Loan payable	`LoansPayableCurrent`	$60.00K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$12.00K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$7.50K	USD	Point-in-time
Total Liabilities	`Liabilities`	$97.46K	USD	Point-in-time
Total Liabilities	`Liabilities`	$31.02K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-81.93K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-89.96K	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquity`	$-37.46K	USD	Point-in-time
Total Stockholders Equity (Deficit)	`StockholdersEquity`	$-29.43K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.59K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$60.00K	USD	Point-in-time

Income Statement 25 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	12 Qtrs
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	1 Quarter
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	1 Quarter
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	1 Quarter
Organization costs	`GeneralAndAdministrativeExpense`	$320.00	USD	12 Qtrs
Professional fees	`ProfessionalFees`	$2.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$8.03K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$89.64K	USD	12 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.00K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$8.03K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$89.96K	USD	12 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.03K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-89.96K	USD	12 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	12 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	1 Quarter
NET LOSS	`IncomeLossFromContinuingOperations`	$-2.00K	USD	1 Quarter
NET LOSS	`IncomeLossFromContinuingOperations`	$-89.96K	USD	12 Qtrs
NET LOSS	`IncomeLossFromContinuingOperations`	$-8.03K	USD	1 Quarter
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`ProfitLoss`	$-8.03K	USD	1 Quarter
Net loss for the period	`ProfitLoss`	$-2.00K	USD	1 Quarter
Net loss for the period	`ProfitLoss`	$-89.96K	USD	12 Qtrs
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	1 Quarter
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	12 Qtrs
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.94K	USD	1 Quarter
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$8.64K	USD	12 Qtrs
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.00K	USD	1 Quarter
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.09K	USD	1 Quarter
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-81.32K	USD	12 Qtrs
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.00K	USD	1 Quarter
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	-	USD	1 Quarter
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	$16.82K	USD	12 Qtrs
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	-	USD	1 Quarter
Loan proceeds	`LoanProceeds`	$60.00K	USD	12 Qtrs
Loan proceeds	`LoanProceeds`	-	USD	1 Quarter
Loan proceeds	`LoanProceeds`	$60.00K	USD	1 Quarter
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$4.50K	USD	1 Quarter
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$12.00K	USD	12 Qtrs
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$1.00K	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$52.50K	USD	12 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$64.50K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$141.32K	USD	12 Qtrs
Net Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	1 Quarter
Net Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$60.00K	USD	12 Qtrs
Net Increase in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$58.41K	USD	1 Quarter
Cash and cash equivalents, beginning of period	`Cash`	$1.59K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$60.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	-	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$1.59K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$60.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	-	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	1 Quarter
Interest paid	`InterestPaid`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaid`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.